enow.com Web Search

  1. Ads

    related to: standard treatment for parkinson's disease dopamine

Search results

  1. Results from the WOW.Com Content Network
  2. Management of Parkinson's disease - Wikipedia

    en.wikipedia.org/wiki/Management_of_Parkinson's...

    In the management of Parkinson's disease, due to the chronic nature of Parkinson's disease (PD), a broad-based program is needed that includes patient and family education, support-group services, general wellness maintenance, exercise, and nutrition. At present, no cure for the disease is known, but medications or surgery can provide relief ...

  3. Hope for Parkinson’s disease symptoms is found in ... - AOL

    www.aol.com/finance/hope-parkinson-disease...

    Parkinson’s disease, which is lifelong, progressive, and has no cure, occurs when brain cells that make dopamine, a chemical that coordinates movement, stop working or die, according to the ...

  4. Dopamine therapy - Wikipedia

    en.wikipedia.org/wiki/Dopamine_therapy

    One dopamine precursor, Levodopa, was the first drug approved specifically for Parkinson's disease. [2] DRT increases dopamine in the brain to optimal levels in order to return motor skills, impulsivity, and decision making to normal function. [3] Although DRT can improve motor skills and decision making in patients with mild to severe ...

  5. George Cotzias - Wikipedia

    en.wikipedia.org/wiki/George_Cotzias

    The first study reporting improvements in patients with Parkinson's disease resulting from treatment with L-dopa was published in 1968. [1] The result was soon confirmed by other investigators and has now become the standard treatment for Parkinsonian symptoms.

  6. Novel method may erase 'bad memory' response to long-term ...

    www.aol.com/novel-method-may-erase-bad-151501517...

    L-DOPA, a treatment for Parkinson’s disease, may induce dyskinesia. Parkinson’s disease is a neurodegenerative disorder caused by the death of dopamine-producing neurons.

  7. FDA Approves AbbVie's Parkinson's Treatment, Medicare ... - AOL

    www.aol.com/finance/fda-approves-abbvies...

    On Thursday, the FDA approved AbbVie Inc’s (NYSE:ABBV) Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for motor fluctuations ...

  1. Ads

    related to: standard treatment for parkinson's disease dopamine